Cargando…

Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer

Digestive cancers-including gastric cancer (GC), colorectal cancer, hepatocellular carcinoma, esophageal cancer, and pancreatic cancer-accounted for 26% of cancer cases and 35% of cancer deaths worldwide in 2018. It is crucial and urgent to develop biomarkers for the diagnosis, prognosis, and therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Wentao, Liu, Jixiang, Liu, Bingya, Li, Quanxue, Sang, Qingqing, Li, Yuan-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055423/ https://www.ncbi.nlm.nih.gov/pubmed/32175327 http://dx.doi.org/10.3389/fmolb.2020.00019

Ejemplares similares

Gene dysregulation analysis builds a mechanistic signature for prognosis and therapeutic benefit in colorectal cancer
por: Li, Quanxue, et al.
Publicado: (2020)

DysRegSig: an R package for identifying gene dysregulations and building mechanistic signatures in cancer
por: Li, Quanxue, et al.
Publicado: (2020)

Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer
por: Zheng, Hang, et al.
Publicado: (2021)

The Involvement of TRIB3 and FABP1 and Their Potential Functions in the Dynamic Process of Gastric Cancer
por: Liu, Songyi, et al.
Publicado: (2021)

Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer
por: Chen, Xiaowei, et al.
Publicado: (2020)

Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression
por: Moreira, Ana M., et al.
Publicado: (2022)

Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Identifying Robust Microbiota Signatures and Interpretable Rules to Distinguish Cancer Subtypes
por: Chen, Lei, et al.
Publicado: (2020)

A Metabolic Gene Signature to Predict Breast Cancer Prognosis
por: Lu, Jun, et al.
Publicado: (2022)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
por: Wang, Yangyang, et al.
Publicado: (2022)

Identification of prognostic gene expression signatures based on the tumor microenvironment characterization of gastric cancer
por: Sang, Qingqing, et al.
Publicado: (2022)

Association Between Polymorphisms in Gastric Cancer Related Genes and Risk of Gastric Cancer: A Case-Control Study
por: Pu, Yan, et al.
Publicado: (2021)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Identification of Pyroptosis-Related Gene Signatures and Construction of the Risk Model to Predict BCR in Prostate Cancer
por: Wang, Miaomiao, et al.
Publicado: (2022)

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature
por: Guan, Qingzhou, et al.
Publicado: (2020)

A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer
por: Cai, Du, et al.
Publicado: (2021)

Diagnostic, Therapeutic, and Prognostic Value of the Thrombospondin Family in Gastric Cancer
por: Lu, Yi, et al.
Publicado: (2021)

Non-coding RNAs regulate mitochondrial dynamics in the development of gastric cancer
por: Chen, Xiatian, et al.
Publicado: (2023)

Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated With Immune Infiltration of Gastric Cancer
por: Lin, Tong, et al.
Publicado: (2021)

Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer
por: Dong, Bingqi, et al.
Publicado: (2021)

Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures
por: Zhang, Congjun, et al.
Publicado: (2021)

Circulating neutrophils activated by cancer cells and M2 macrophages promote gastric cancer progression during PD-1 antibody-based immunotherapy
por: Zhou, Chenfei, et al.
Publicado: (2023)

Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements
por: Shao, Su, et al.
Publicado: (2022)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer
por: Ye, Ying, et al.
Publicado: (2021)

Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer
por: Liu, Bangquan, et al.
Publicado: (2022)

Identification of circRNA Biomarker for Gastric Cancer through Integrated Analysis
por: Hossain, Md. Tofazzal, et al.
Publicado: (2022)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Huang, Anmin, et al.
Publicado: (2022)

Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer
por: Miao, Ti-wei, et al.
Publicado: (2022)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
por: Liu, Shixian, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Exosomal miR-590-5p in Serum as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zheng, Guo-Dian, et al.
Publicado: (2021)

KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Wu, Qiulin, et al.
Publicado: (2020)

Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2022)

XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer
por: Wu, Zhengchun, et al.
Publicado: (2020)

Corrigendum: Identification of circRNA biomarker for gastric cancer through integrated analysis
por: Hossain, Md. Tofazzal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ijvffeovfgccumh8ug0e49ahn